课题基金 / 基金详情

项目摘要

项目成果

Jenny E. Gumperz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): NKT cells are a population of regulatory T cells that is known to be able to potently modulate immune responses. The antigens that control NKT cell activation are lipids and glycolipids presented by CD1d molecules. A remarkable characteristic of NKT cells is that many are autoreactive to self antigens. This allows them to become activated even when there is no foreign antigenic challenge, and may be critical for their endogenous immunoregulatory effects. The auto-antigens recognized by human NKT cells have not been identified, and little is known about how their presentation is regulated. Here we will: i) characterize the endogenous ligands presented by human CD1d molecules, and analyze which ones are antigenic for NKT cells; ii) follow up on our preliminary results, which indicate that an intercellular lipid messenger called lyso- phosphatidylcholine (LPC) that is produced under inflammatory conditions, is a self antigen that can be recognized by many human NKT cells; iii) investigate the cellular and molecular requirements for CD1d-mediated auto-antigen presentation to NKT cells. These studies will provide new information about the lipid characteristics that are important for binding to human CD1d molecules and for recognition by NKT cells, and will explore how NKT cell activation is linked to broader physiological processes of inflammation through recognition of bio-active lipid mediators as self antigens, and will provide critical insights into the mechanisms by which CD1d- mediated auto-antigen presentation is regulated by APCs. PUBLIC HEALTH RELEVANCE: NKT cells are autoreactive regulatory T cells that recognize lipids and glycolipids as antigens presented by CD1d molecules. The molecular identity of the auto-antigens recognized by human NKT cells remains unknown. In this grant we will: i) identify constitutively presented cellular ligands that are recognized by human NKT cells; ii) investigate lipid messengers as putative inducible auto-antigens that may directly link NKT cell activation to inflammatory responses; and iii) analyze cellular and molecular requirements for auto-antigen presentation by CD1d.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of iPSC-derived iNKT cells to promote hematopoietic engraftment
  • 批准号:
    10525780
  • 项目类别:
  • 资助金额:
    $23.33万
  • 财政年份:
    2022
  • 负责人:
    Jenny E. Gumperz
  • 依托单位:
Development of iPSC-derived iNKT cells to promote hematopoietic engraftment
  • 批准号:
    10632065
  • 项目类别:
  • 资助金额:
    $19.44万
  • 财政年份:
    2022
  • 负责人:
    Jenny E. Gumperz
  • 依托单位:
Mechanisms of iNKT cell anti-viral adjuvancy
  • 批准号:
    10456109
  • 项目类别:
  • 资助金额:
    $38.25万
  • 财政年份:
    2018
  • 负责人:
    Jenny E. Gumperz
  • 依托单位:
Mechanisms of iNKT cell anti-viral adjuvancy
  • 批准号:
    9757690
  • 项目类别:
  • 资助金额:
    $38.25万
  • 财政年份:
    2018
  • 负责人:
    Jenny E. Gumperz
  • 依托单位:
海外基金